Literature DB >> 1751847

A scale for estimating the health status of opioid users.

S Darke1, J Ward, D Zador, G Swift.   

Abstract

The health status of injecting drug users has both clinical and research relevance. In order to evaluate the impact of treatments for opiate dependence on drug users' health status we need valid and reliable instruments which are short and easily administered by non-medical personnel. This paper describes the construction of a brief interviewer administered scale for assessing the current health status of injecting drug users. Data evaluating its reliability and validity are presented which indicate that the scale has excellent psychometric properties.

Mesh：

Substances：

Year:  1991        PMID： 1751847     DOI： 10.1111/j.1360-0443.1991.tb01707.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN： 0952-0481


  7 in total

1.  Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users.

Authors:  Christian Haasen; Michael Prinzleve; Michael Gossop; Gabriele Fischer; Miguel Casas
Journal:  World Psychiatry       Date:  2005-10       Impact factor: 49.548

2.  The effect of hepatitis C virus infection on health-related quality of life in prisoners.

Authors:  Hla-Hla Thein; Tony Butler; Murray Krahn; William Rawlinson; Michael H Levy; John M Kaldor; Gregory J Dore
Journal:  J Urban Health       Date:  2006-03       Impact factor: 3.671

3.  Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study.

Authors:  M Gossop; J Marsden; D Stewart; P Lehmann; J Strang
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

4.  Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study.

Authors:  Bernd Schulte; Christiane S Schmidt; Jakob Manthey; Lisa Strada; Stefan Christensen; Konrad Cimander; Herbert Görne; Pavel Khaykin; Norbert Scherbaum; Stefan Walcher; Stefan Mauss; Ingo Schäfer; Uwe Verthein; Jürgen Rehm; Jens Reimer
Journal:  Open Forum Infect Dis       Date:  2020-08-13       Impact factor: 3.835

5.  Study protocol for a non-inferiority trial of a blended smoking cessation treatment versus face-to-face treatment (LiveSmokefree-Study).

Authors:  Lutz Siemer; Marcel E Pieterse; Marjolein G J Brusse-Keizer; Marloes G Postel; Somaya Ben Allouch; Robbert Sanderman
Journal:  BMC Public Health       Date:  2016-11-24       Impact factor: 3.295

6.  Effectiveness of a web-based treatment program using intensive therapeutic support for female patients with bulimia nervosa, binge eating disorder and eating disorders not otherwise specified: study protocol of a randomized controlled trial.

Authors:  Elke D ter Huurne; Marloes G Postel; Hein A de Haan; Cor A J DeJong
Journal:  BMC Psychiatry       Date:  2013-11-16       Impact factor: 3.630

7.  Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study.

Authors:  Lisa Strada; Christiane Sybille Schmidt; Moritz Rosenkranz; Uwe Verthein; Norbert Scherbaum; Jens Reimer; Bernd Schulte
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.